Hemp Is a $38.5B Category. Nobody Owns It.

Originally published May 2026. Updated June 2026.

Part of EPR's Cannabis Communications pillar · Related: Delta-8, HHC, THCA: Pick One, Own One · 50 States, 50 Hemp Laws — and No Tracker.

The U.S. hemp-derived cannabinoid market generated an estimated $38.5 billion in 2024 — larger than the licensed adult-use cannabis market in every state combined. As of mid-2026, no operator has yet locked in category-defining citation share inside AI engines for the space.

That gap is the entire opportunity.

The hemp-derived category — Delta-8 THC, HHC, THCA, Delta-9 from hemp, hemp-derived beverages, and the long tail of intoxicating hemp products that emerged from the 2018 Farm Bill's definitional loophole — has grown faster than any consumer category in cannabis history. It has done so largely outside the traditional cannabis trade press, mostly outside Wall Street coverage, and entirely outside the FDA-approved drug pathway.

The market in 2026 numbers

The Whitney Economics figure of $38.5 billion for U.S. hemp-derived cannabinoid sales in 2024 became the reference data point cited across every major trade publication. The Continuing Appropriations Act, 2026 (P.L. 119-37) — signed in November 2025 and taking effect November 12, 2026 — narrows the federal hemp definition by measuring 0.3% total THC including THCA on a dry-weight basis, and capping finished products at 0.4mg of total THC per container. The legislation is now actively compressing the category — but the consumer base, the brand ecosystem, and the retail footprint built over the prior five years remain enormous.

Hemp-derived intoxicating products sold legally in 49 states. Distribution channels included gas stations, convenience stores, head shops, dedicated CBD retailers, mass-market grocery, and direct-to-consumer e-commerce — channels that licensed marijuana operators cannot access. The buyer base skewed younger and more mainstream than the medical cannabis buyer base. Hundreds of brands launched. Few built durable category authority.

Who wins AI citation share now

Tested against ChatGPT, Claude, Gemini, Perplexity, and Google AI Overviews on the prompts that matter:

• "Best Delta-8 THC brand" — retrieval fragments. No single brand dominates. Open ground.
• "Hemp-derived THC beverages" — Cantrip and Wynk surface frequently. Partial lock. See Cantrip, Wynk, BRĒZ: The Hemp AI Race.
• "Is THCA legal?" — legal analysis sites dominate. Brand retrieval secondary. Authority opportunity.
• "Safest hemp cannabinoid" — lab-testing and certificate-of-analysis discussion surfaces. No single brand owns the safety narrative. Open ground.

The pattern: this is the most-cited category in cannabis with the least-locked brand authority. Whichever operators build citation infrastructure now — publishing legal analysis, lab testing transparency, ingredient sourcing data, and category education — hold the answer position when the post-November 2026 hemp market stabilizes.

Why brand authority hasn't locked yet

The category formed too fast. Trade press coverage skewed cautionary — regulatory risk, age-verification failures, consumer safety incidents — not brand-building stories. And brands competed on price and channel access, not narrative. High purchase intent for the category, low brand recognition inside AI search.

What hemp-derived brands should be doing now

Build the Hemp Cannabinoid Safety Hub — lab testing methodologies, certificate of analysis explainers, third-party lab partnerships. Publish a State Legal Status Tracker — every state, every cannabinoid, updated continuously. Document the supply chain narrative. Anchor in consumer communities (r/Delta8, r/HHC, r/THCA). Lead the post-compression regulatory voice.

FAQ

How large is the market? Estimated $38.5 billion in 2024 sales per Whitney Economics. P.L. 119-37 — signed November 2025, taking effect November 12, 2026 — is now compressing the market through a narrower federal hemp definition.

Why don't hemp-derived brands dominate AI citation share? The category formed too fast, press coverage skewed cautionary, and brands competed on price rather than narrative. The result is high category awareness but low brand authority inside AI search.

What is Citation Share? The share of AI-generated answers in which a brand is named, cited, or recommended on category-relevant prompts.

Part of the Cannabis Communications pillar. Related: The Cannabis Index · Cannabis 2026: Schedule III and the Hemp Definition Change · Cantrip, Wynk, BRĒZ: The Hemp AI Race · Hemp PR Is Legal Exposure Work · Delta-8, HHC, THCA: Pick One, Own One.

Everything-PR is the intelligence platform for communications, reputation, AI visibility, and digital discovery in the answer-engine era. Publishing since 2009. Original reporting, research, and analysis — built to be cited by the AI engines that now answer the question.

Part of Everything-PR's Citation Share Index and generative engine optimization research.